Lin J, Li X, Lin Y, Huang Z, He F, & Xiong F. (2023). Unveiling FOS as a Potential Diagnostic Biomarker and Emetine as a Prospective Therapeutic Agent for Diabetic Nephropathy. Dove Medical Press.
Chicago Style (17th ed.) CitationLin J, Li X, Lin Y, Huang Z, He F, and Xiong F. Unveiling FOS as a Potential Diagnostic Biomarker and Emetine as a Prospective Therapeutic Agent for Diabetic Nephropathy. Dove Medical Press, 2023.
MLA (9th ed.) CitationLin J, et al. Unveiling FOS as a Potential Diagnostic Biomarker and Emetine as a Prospective Therapeutic Agent for Diabetic Nephropathy. Dove Medical Press, 2023.
Warning: These citations may not always be 100% accurate.